The emergence of multi-drug resistant strains spanning bacteria, fungi, viruses, and parasites poses a severe threat to public health and the economy. Tackling antimicrobial resistance requires swiftly identifying new agents with unique mechanisms. Multicomponent reactions offer a vital method to produce diverse analogs in various heterocyclic compounds, with broad medicinal applications. This study synthesized a range of peptidomimetics using isocyanide-based multicomponent Ugi reactions. These analogs were screened for antimicrobial efficacy against both Gram-negative (Escherichia coli, Pseudomonas aeruginosa) and Gram-positive bacteria (Staphylococcus aureus, Bacillus subtilis, Staphylococcus aureus IGMS-01), with ampicillin as a reference antibiotic, and for antifungal activity against Candida albicans, using fluconazole as a reference. The compounds showed moderate but significant efficacy across all tests. Docking analysis with microbial proteins revealed notable binding affinities for peptidomimetics 5h (N-(2-(1H-indol-3-yl)ethyl)-N-(1-(4-chlorophenyl)-2-(cyclohexylamino)-2-oxoethyl)stearamide) and 5i (N-(2-(1H-indol-3-yl)ethyl)-N-(1-(4-chlorophenyl)-2-(cyclohexylamino)-2-oxoethyl)oleamide). Molecular dynamics simulations confirmed stable interactions between the ligands and proteins. Furthermore, the long alkyl chain analogs demonstrated the ability to form organo/hydrogels, facilitating the incorporation of silver sulfadiazine for controlled antimicrobial release. This innovative approach enhances drug dispersion within the gel structure, effectively inhibiting microbial growth. These findings highlight the potential of these adaptable materials to advance drug development efforts in the foreseeable future.